StoneBridge Partners, LLC, which is an international finance communication and consulting entity reported the launch of a comprehensive business assessment of Medical Marijuana Inc (OTCMKTS:MJNA) covered in a comprehensive report.

The report, which shows the firm’s formation and current businesses, also provides insight into the seen opportunities in the budding growth market of marijuana. It explores the firm’s diversified portfolio of cannabis brands and organizations that continue to grow as new markets emerge and existing markets persist to advance. With investments in pharmaceutical and biotechnology applications as well as stronghold lifestyle and consumer brands, Medical Marijuana is well positioned to excel in the growing legalized medical cannabis market.

The experts speak

Michael Berger of StoneBridge said that they are thrilled to take on this assignment as company is comprised of many investments, partners, brands and subsidiaries. The firm’s proficiency is in the cannabis finance division and they were remarkably interested in researching and offering an assessment of the first publicly traded pot firm.

The research report, which can be downloaded from the firm’s site, comes at a crucial time in cannabis legislation. As more than 8 states passed legislative reform in November election, the industry for cannabis is all prepared to grow at unparalleled rates in the coming period. Medical Marijuana has witnessed considerable volatility in its shares price and market capitalization over the past few weeks and the StoneBridge report is as updated at the time of its launch. StoneBridge will continue to monitor the firm’s performance as well as other publically traded firms in the cannabis sectors and offer readers with updates.

StoneBridge Partners is a renowned corporate consulting and communications firm focused on helping private and public firms generate awareness, communicate with the market, raise capital and engage investors. They presently serve customers in the financial media, biotechnology and cannabis industries. The research firm brings expertise in equity research, advisory services, fundraising, marketing and strategy to drive results in the cannabis industry.